Keywords: cypher, stent, superior, bs, taxus, health, care

J&J's Cypher stent not superior to BS' Taxus

Article | 14 March 2005

Print This

US health care giant Johnson & Johnson has been unable to demonstrate in a clinical trial that its Cypher sirolimus-eluting coronary ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in